Efficacy of INM004 in Children With STEC-HUS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The objectives of this study are to evaluate the efficacy, safety, and pharmacokinetics of INM004 in pediatric patients with Hemolytic Uremic Syndrome associated to infection by Shiga toxin-producing Escherichia coli (STEC-HUS).
Epistemonikos ID: 5573ef3f17f2cc317062f5746eec41c0413337a1
First added on: May 16, 2024